Loading…
Cognoa offers Canvas Dx, the first and only FDA-authorized AI diagnostic tool designed to help clinicians diagnose or rule out autism in children aged 1.5 to 6 years within days. The company aims to reduce diagnostic delays and inequities by enabling early, rapid, and equitable diagnosis of developmental conditions.
AI named Cognoa in March 2026.